Professor Mark Morrison
Professor

Mark Morrison

Email: 
Phone: 
+61 7 344 36957

Availability

Professor Mark Morrison is:
Available for supervision

Fields of research

Biomedical and Clinical Sciences Clinical microbiology Clinical sciences Gastroenterology and hepatology Medical biochemistry and metabolomics Medical microbiology

Qualifications

  • Bachelor of Science, University of New South Wales
  • Masters (Research) of Science, James Cook University
  • Doctor of Philosophy, University of Illinois

Search Professor Mark Morrison’s works on UQ eSpace

446 works between 1990 and 2026
All (446) Journal Article (257) Conference Publication (181) Book Chapter (8)

181 - 200 of 446 works

2019

Conference Publication

2125. Staphylococcus Species Identification by Fourier Transform Infrared (FTIR) Spectroscopic Techniques: A Cross-Lab Study

Tsutsumi, Tamao, Shah, Alok, Lam, Lisa M T, Schlebusch, Sanmarie, Krueger, Annika, Frazer, Ian, Hugenholtz, Phil, Soyer, H Peter, Morrison, Mark, Hill, Michelle, Sedman, Jacqueline and Ismail, Ashraf (2019). 2125. Staphylococcus Species Identification by Fourier Transform Infrared (FTIR) Spectroscopic Techniques: A Cross-Lab Study. IDWeek 2019, Washington, DC, United States, 2-6 October 2019. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ofid/ofz360.1805

2125. Staphylococcus Species Identification by Fourier Transform Infrared (FTIR) Spectroscopic Techniques: A Cross-Lab Study

2019

Journal Article

Dietary intake influences gut microbiota development of healthy Australian children from the age of one to two years

Matsuyama, Misa, Morrison, Mark, Cao, Kim-Anh Lê, Pruilh, Solange, Davies, Peter S. W., Wall, Clare, Lovell, Amy and Hill, Rebecca J. (2019). Dietary intake influences gut microbiota development of healthy Australian children from the age of one to two years. Scientific Reports, 9 (1) 12476, 12476. doi: 10.1038/s41598-019-48658-4

Dietary intake influences gut microbiota development of healthy Australian children from the age of one to two years

2019

Journal Article

Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease

Raj, Ashok S., Shanahan, Erin R., Tran, Cuong D., Bhat, Purnima, Fletcher, Linda M., Vesey, David A., Morrison, Mark, Holtmann, Gerald and Macdonald, Graeme A. (2019). Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease. Clinical and Translational Gastroenterology, 10 (8) e00068, e00068. doi: 10.14309/ctg.0000000000000068

Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease

2019

Conference Publication

ENTERIC METHANE OR HYDROGEN PRODUCTION IN PATIENTS WITH UNEXPLAINED GASTROINTESTINAL SYMPTOMS: ASSOCIATIONS WITH AGE, SYMPTOMS AND PROTON PUMP INHIBITORS

Shah, Ayesha, Rich, Justin, Koloski, Natasha A., Morrison, Mark and Holtmann, Gerald J. (2019). ENTERIC METHANE OR HYDROGEN PRODUCTION IN PATIENTS WITH UNEXPLAINED GASTROINTESTINAL SYMPTOMS: ASSOCIATIONS WITH AGE, SYMPTOMS AND PROTON PUMP INHIBITORS. Digestive Disease Week (DDW), San Diego Ca, May 18-21, 2019. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC.

ENTERIC METHANE OR HYDROGEN PRODUCTION IN PATIENTS WITH UNEXPLAINED GASTROINTESTINAL SYMPTOMS: ASSOCIATIONS WITH AGE, SYMPTOMS AND PROTON PUMP INHIBITORS

2019

Conference Publication

A COMPARISON OF PATIENTS WITH UNEXPLAINED (FUNCTIONAL) SYMPTOMS OR ORGANIC GASTROINTESTINAL (GI) DISEASE: SYMPTOM SEVERITY, PSYCHIATRIC COMORBIDITIES, GASTROINTESTINAL DYSBIOSIS AND IMMUNE ACTIVIATION

Shah, Ayesha, Do, Anh, Keely, Simon, Walker, Marjorie M., Hansen, Teressa J., Rich, Justin, Jones, Michael P., Koloski, Natasha A., Talley, Nicholas J., Morrison, Mark and Holtmann, Gerald J. (2019). A COMPARISON OF PATIENTS WITH UNEXPLAINED (FUNCTIONAL) SYMPTOMS OR ORGANIC GASTROINTESTINAL (GI) DISEASE: SYMPTOM SEVERITY, PSYCHIATRIC COMORBIDITIES, GASTROINTESTINAL DYSBIOSIS AND IMMUNE ACTIVIATION. Digestive Disease Week (DDW), San Diego Ca, May 18-21, 2019. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC.

A COMPARISON OF PATIENTS WITH UNEXPLAINED (FUNCTIONAL) SYMPTOMS OR ORGANIC GASTROINTESTINAL (GI) DISEASE: SYMPTOM SEVERITY, PSYCHIATRIC COMORBIDITIES, GASTROINTESTINAL DYSBIOSIS AND IMMUNE ACTIVIATION

2019

Journal Article

Analysis of the effects of dietary pattern on the oral microbiome of elite endurance athletes

Murtaza, Nida, Burke, Louise, Vlahovich, Nicole, Charlesson, Bronwen, O’Neill, Hayley, Ross, Megan, Campbell, Katrina, Krause, Lutz and Morrison, Mark (2019). Analysis of the effects of dietary pattern on the oral microbiome of elite endurance athletes. Nutrients, 11 (3) 614, 614. doi: 10.3390/nu11030614

Analysis of the effects of dietary pattern on the oral microbiome of elite endurance athletes

2019

Conference Publication

Characterisation of Crohn's disease mucosa-associated microbiota by a novel combination of microbe culture and metagenomic sequencing (MC-MGS): the ENIGMA study

Berendsen, E. M., Hoedt, E. C., Teh, J. -J., Zhang, J., Zhang, F., Liu, Q., Hamilton, A. L., Wilson-O'Brien, A., Ching, J., Sung, J. J., Yu, J., Ng, S. C., Kamm, M. A. and Morrison, M. (2019). Characterisation of Crohn's disease mucosa-associated microbiota by a novel combination of microbe culture and metagenomic sequencing (MC-MGS): the ENIGMA study. OXFORD: OXFORD UNIV PRESS. doi: 10.1093/ecco-jcc/jjy222.976

Characterisation of Crohn's disease mucosa-associated microbiota by a novel combination of microbe culture and metagenomic sequencing (MC-MGS): the ENIGMA study

2019

Journal Article

Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease

Shah, Ayesha, Morrison, Mark, Burger, Daniel, Martin, Neal, Rich, Justin, Jones, Mike, Koloski, Natasha, Walker, Marjorie M., Talley, Nicholas J. and Holtmann, Gerald J. (2019). Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 49 (6), 624-635. doi: 10.1111/apt.15133

Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease

2019

Conference Publication

Proteus is a key candidate in the pathogenesis of Crohn's disease: mucosa, stool genomics and functional analysis: the ENIGMA study

Zhang, J., Berendsen, E., Hoedt, E., Liu, Q., Zhang, F., Xu, Z., Hamilton, A., Brien, A. W. O', Ching, J., Sung, J. J., Kamm, M. A., Morrison, M., Yu, J. and Ng, S. C. (2019). Proteus is a key candidate in the pathogenesis of Crohn's disease: mucosa, stool genomics and functional analysis: the ENIGMA study. OXFORD: OXFORD UNIV PRESS. doi: 10.1093/ecco-jcc/jjy222.958

Proteus is a key candidate in the pathogenesis of Crohn's disease: mucosa, stool genomics and functional analysis: the ENIGMA study

2019

Conference Publication

Urease-positive proteobacteria in Crohn's disease identified by novel ex vivo mucosal microbe culture combined with metagenomic sequencing (MC-MGS): the ENIGMA study

Berendsen, E. M., Hoedt, E. C., Teh, J. -J., Zhang, J., Zhang, F., Liu, Q., Hamilton, A. L., Ching, J., Sung, J. J., Yu, J., Ng, S. C., Kamm, M. A. and Morrison, M. (2019). Urease-positive proteobacteria in Crohn's disease identified by novel ex vivo mucosal microbe culture combined with metagenomic sequencing (MC-MGS): the ENIGMA study. OXFORD: OXFORD UNIV PRESS. doi: 10.1093/ecco-jcc/jjy222.973

Urease-positive proteobacteria in Crohn's disease identified by novel ex vivo mucosal microbe culture combined with metagenomic sequencing (MC-MGS): the ENIGMA study

2019

Journal Article

The effects of dietary pattern during intensified training on stool microbiota of elite race walkers

Murtaza, Nida, Burke, Louise, Vlahovich, Nicole, Charlesson, Bronwen, O’ Neill, Hayley, Ross, Megan, Campbell, Katrina, Krause, Lutz and Morrison, Mark (2019). The effects of dietary pattern during intensified training on stool microbiota of elite race walkers. Nutrients, 11 (2) 261, 261. doi: 10.3390/nu11020261

The effects of dietary pattern during intensified training on stool microbiota of elite race walkers

2019

Journal Article

Probiotics for the prevention of gestational diabetes mellitus in overweight and obese women: findings from the SPRING double-blind randomized controlled trial

Callaway, Leonie K., McIntyre, H. David, Barrett, Helen L., Foxcroft, Katie, Tremellen, Anne, Lingwood, Barbara E., Tobin, Jacinta M., Wilkinson, Shelley, Kothari, Alka, Morrison, Mark, O’Rourke, Peter, Pelecanos, Anita and Dekker Nitert, Marloes (2019). Probiotics for the prevention of gestational diabetes mellitus in overweight and obese women: findings from the SPRING double-blind randomized controlled trial. Diabetes Care, 42 (3), dc182248-371. doi: 10.2337/dc18-2248

Probiotics for the prevention of gestational diabetes mellitus in overweight and obese women: findings from the SPRING double-blind randomized controlled trial

2019

Conference Publication

Factorial analysis-based assessment of the Mucosa Associated Microbiome

Holtmann, Gerald, Morrison, Mark, Talley, Nicholas, Koloski, Natasha, Shah, Ayesha and Jones, Michael (2019). Factorial analysis-based assessment of the Mucosa Associated Microbiome. Asia Pacific Digestive Week, Kolkata, India, 12–15 December 2019. Hoboken, NJ United States: Wiley.

Factorial analysis-based assessment of the Mucosa Associated Microbiome

2019

Conference Publication

Development and validation of tools to assess food additive intake: the ENIGMA study

Trakman, G., Lin, W. Y. Y., Wilson-O'brien, A., Ching, J., Tang, W., Orr, L., Stanley, A., Hamilton, A. L., Morrison, M., Yu, J., Sung, J. J., Ng, S. C. and Kamm, M. A. (2019). Development and validation of tools to assess food additive intake: the ENIGMA study. 14th Congress of ECCO, Copenhagen, Denmark, 6-9 March 2019. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjy222.896

Development and validation of tools to assess food additive intake: the ENIGMA study

2019

Conference Publication

Modulating NFkB signaling in skin wounds through pharmacological or probiotic intervention using Faecalibacterium prausnitzii extracts

Stefia, L., Lee, J., Legrand, J., Rodero, M., Patel, J., Linedale, R., Burman, S., Morrison, M. and Khosrotehrani, K. (2019). Modulating NFkB signaling in skin wounds through pharmacological or probiotic intervention using Faecalibacterium prausnitzii extracts. 49th Annual Meeting of the European-Society-for-Dermatological-Research (ESDR), Bordeaux, France, 18-21 September 2019. New York, NY, United States: Elsevier. doi: 10.1016/j.jid.2019.07.663

Modulating NFkB signaling in skin wounds through pharmacological or probiotic intervention using Faecalibacterium prausnitzii extracts

2019

Journal Article

Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis

Shah, Ayesha, Crawford, Darrel, Burger, Daniel, Martin, Neal, Walker, Marjorie, Talley, Nicholas J., Tallis, Caroline, Jones, Michael, Stuart, Katherine, Keely, Simon, Lewindon, Peter, MacDonald, Graeme A., Morrison, Mark and Holtmann, Gerald J. (2019). Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis. Seminars in Liver Disease, 39 (4), 432-441. doi: 10.1055/s-0039-1688501

Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis

2019

Conference Publication

The common food additives sodium sulfite and polysorbate 80 have a profound inhibitory effect on the commensal, anti-inflammatory bacterium Faecalibacterium prausnitzii: the ENIGMA study

Loayza, J. J. Jimenez, Berendsen, E. M., Teh, J. -J., Hoedt, E. C., Zhang, J., Liu, Q., Hamilton, A. L., Wilson-O'Brien, A., Trakman, G. L., Lin, W., Tang, W., Ching, J., Or, L. M. H., Sung, J. J., Yu, J., Ng, S. C., Kamm, M. A. and Morrison, M. (2019). The common food additives sodium sulfite and polysorbate 80 have a profound inhibitory effect on the commensal, anti-inflammatory bacterium Faecalibacterium prausnitzii: the ENIGMA study. 14th Congress of ECCO, Copenhagen, Denmark, 6-9 March 2019. Oxford, United Kingdom: Oxford University Press.

The common food additives sodium sulfite and polysorbate 80 have a profound inhibitory effect on the commensal, anti-inflammatory bacterium Faecalibacterium prausnitzii: the ENIGMA study

2019

Conference Publication

Skin bacterial composition is driven largely by host genetic background and polymorphisms regulating innate immunity

Legrand, J., Muller, N., Baz, B., Morahan, G., Walker, G., Morrison, M. and Khosrotehrani, K. (2019). Skin bacterial composition is driven largely by host genetic background and polymorphisms regulating innate immunity. 49th Annual Meeting of the European-Society-for-Dermatological-Research (ESDR), Bordeaux, France, 18-21 September 2019. New York, NY United States: Elsevier. doi: 10.1016/j.jid.2019.07.631

Skin bacterial composition is driven largely by host genetic background and polymorphisms regulating innate immunity

2018

Journal Article

Gastroduodenal "Dysbiosis": a new clinical entity

Shah, Ayesha, Morrison, Mark and Holtmann, Gerald J. (2018). Gastroduodenal "Dysbiosis": a new clinical entity. Current Treatment Options in Gastroenterology, 16 (4), 591-604. doi: 10.1007/s11938-018-0207-x

Gastroduodenal "Dysbiosis": a new clinical entity

2018

Journal Article

Breastfeeding: a key modulator of gut microbiota characteristics in late infancy

Matsuyama, M., Gomez-Arango, L. F., Fukuma, N. M., Morrison, M., Davies, P. S. W. and Hill, R. J. (2018). Breastfeeding: a key modulator of gut microbiota characteristics in late infancy. Journal of Developmental Origins of Health and Disease, 10 (02), 1-8. doi: 10.1017/s2040174418000624

Breastfeeding: a key modulator of gut microbiota characteristics in late infancy

Current funding

  • 2026
    Collaboration with Australasian Gastrointestinal Research Foundation
    Australasian Gastro Intestinal Research Foundation
    Open grant
  • 2025 - 2026
    Metabolomic signatures of the duodenal mucosa associated microbiota in Primary Sclerosing Cholangitis (PSC) and its associated Inflammatory Bowel Disease (IBD)
    University of Newcastle
    Open grant
  • 2024 - 2029
    Centre of Research Excellence in Transforming Gut Health (a 2024 NHMRC Centres of Research Excellence grant led by The University of Newcastle)
    University of Newcastle
    Open grant
  • 2024 - 2027
    Harnessing microbial immunomodulatory function to improve treatment of inflammatory bowel diseases
    NHMRC IDEAS Grants
    Open grant
  • 2022 - 2026
    Microbiome Manipulation to Treat and Cure Inflammatory Bowel Disease (NHMRC Investigator Grant led by CI Kamm University of Melbourne)
    University of Melbourne
    Open grant
  • 2021 - 2026
    Drugs from Bugs: Developing New Inflammatory Bowel Disease Drugs from Gut Bacteria-Derived Bioactives
    United States Congressionally Directed Medical Research Programs - Peer Reviewed Medical Research Program
    Open grant

Past funding

  • 2024 - 2025
    Onco-Derm: a single site prospective analysis of skin microbiome as a predictor of toxicity in patients receiving immune checkpoint inhibitor therapy
    Microba Pty Ltd
    Open grant
  • 2023 - 2024
    Responses of duodenal spheroid cultures to the secretomes of duodenal microbiota from patients with and without disorders of gut brain interactions (NHMRC CRE led by University of Newcastle)
    University of Newcastle
    Open grant
  • 2023 - 2025
    Investigating gastrointestinal biofilms regarding biochemistry and links with clinical manifestations (2023 MSHRSS Co-funded Collaboration Grant led by MSH)
    Metro South Research Support Scheme Co-funded Collaboration Grant
    Open grant
  • 2022 - 2023
    The effects of variable doses of STW 5 and STW 5-II on bacterial isolates from the duodenum and the duodenal mucosa-associated microbiomes from subjects with and without functional GI symptoms
    Bayer - Steigerwald Arzneimittelwerk GmbH
    Open grant
  • 2022 - 2025
    Defining host immune and microbial determinants of disease trajectory in mycobacterial infection
    Metro South Hospital and Health Service
    Open grant
  • 2022
    Linking the presence of live Ileal-derived bacteria in the joint as a triggering factor for the development of Spondyloarthropathy.
    Arthritis Foundation of Australia
    Open grant
  • 2021 - 2022
    Impacts of food additives on the duodenal mucosa-associated microbiota
    University of Newcastle
    Open grant
  • 2021 - 2026
    Bringing Archaeal biodiversity to life from native Australian herbivores
    ARC Discovery Projects
    Open grant
  • 2020 - 2024
    Modulation of the Gastrointestinal Microbiome with probiotics and subsequent Methane production as a novel approach to treat constipation: A Proof of Principle Study (TRI Sport Grant led by PAH)
    Metro South Hospital and Health Service
    Open grant
  • 2020 - 2021
    Comparative Genomic Sequencing of selected strains of probiotic bacteria - Phase II
    Innovation Connections
    Open grant
  • 2020 - 2021
    Functionally characterizing IBD dysbiosis and harnessing gut bioactives to suppress IL-23 driven inflammation
    The Global Grants for Gut Health
    Open grant
  • 2020 - 2025
    Creating an evidence base for clinical care: A randomized controlled study examining the efficacy of the low FODMAP diet for... (MRFF EPCDR Endometriosis Grant led by Monash)
    Monash University
    Open grant
  • 2020 - 2025
    Targeting the gut microbiome as a treatment for Primary Sclerosing Cholangitis: The Queensland Clinical Network Study
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2019 - 2024
    Centre for Research Excellence in Digestive Health (NHMRC CRE administered by University of Newcastle)
    University of Newcastle
    Open grant
  • 2019 - 2020
    Comparative Genomic Sequencing of selected strains of probiotic bacteria
    Innovation Connections
    Open grant
  • 2017 - 2020
    Invention of a Genetic Toolkit for Immunomodulatory Gut Bacteria to Expedite the Development of New Crohn's Disease Therapeutics
    United States Congressionally Directed Medical Research Programs - Peer Reviewed Medical Research Program
    Open grant
  • 2017 - 2018
    Prebiotic Study of Faecal Samples - Using Diets Rich in Dietary Fibre to Improve Bowel Habit and Sense of Wellbeing
    Monash University
    Open grant
  • 2017 - 2022
    The ENIGMA project: Eastern Inflammatory Bowel Disease Gut Microbiota
    Australasian Gastro Intestinal Research Foundation
    Open grant
  • 2017 - 2020
    Epithelial metabolism as a mediator of host-microbiome interactions in inflammatory bowel disease (NHMRC Project Grant administered by The University of Newcastle)
    University of Newcastle
    Open grant
  • 2017 - 2018
    Linking maternal and infant microbiome: effects of GDM or effects of probiotics?
    Diabetes Australia Research Program
    Open grant
  • 2016 - 2019
    Rapid functional and taxonomic skin microbe characterisation
    ARC Linkage Projects
    Open grant
  • 2016 - 2020
    Design rules for nutritionally-functional grains
    ARC Linkage Projects
    Open grant
  • 2016
    Establishing a gnotobiotic germ-free mouse facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    Instrumentation for the analysis of cellular and metabolic phenotypes
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    Modification of the microbiome to protect against spondyloarthropathy in SKG mice
    Arthritis Foundation of Australia
    Open grant
  • 2016
    The Australian human microbiota project-microbe isolation facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2017
    Microbiome in highly trained athletes and response to dietary change
    Australian Institute Sport
    Open grant
  • 2015
    Design rules for nutritionally-functional starches
    UQ Collaboration and Industry Engagement Fund - Seed Research Grant
    Open grant
  • 2015 - 2017
    Evolution of the marsupial gut microbiome and adaptation to eucalypt toxins
    ARC Discovery Projects
    Open grant
  • 2015 - 2018
    Pathophysiology of functional dyspepsia: Integration of upper gut function, inflammation and a systems biology approach.
    NHMRC Project Grant
    Open grant
  • 2015 - 2016
    Your microbiome or your mother's? The relationship between the microbiomes of mothers and babies
    Royal Brisbane and Women's Hospital
    Open grant
  • 2014 - 2017
    Interactions between host and the gut microbiome in the pathogenesis of ankylosing spondylitis and Crohn's disease
    NHMRC Project Grant
    Open grant
  • 2014 - 2015
    Bringing genomes to life: isolation of genetically tractable, not-yet-cultured members of the human microbiota using metaparental mating methods
    PA Research Foundation
    Open grant
  • 2014 - 2018
    Determinants of progression of actinic keratoses to squamous cancer
    NHMRC Project Grant
    Open grant

Availability

Professor Mark Morrison is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

For media enquiries about Professor Mark Morrison's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au